Yahoo Finance Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow?
Whether or not you buy the highest-yielding Dow stocks depends on how you invest. Here is a look at each of them.
Whether or not you buy the highest-yielding Dow stocks depends on how you invest. Here is a look at each of them.
ARLINGTON, Va. & WASHINGTON, October 03, 2023--The pathway for underserved small businesses owners to obtain affordable owner-occupied commercial real estate mortgages just got easier — thanks to a new loan product meant to help small businesses in low-to-moderate income areas. By working in these disinvested communities, this loan product will also help entrepreneurs of color and female entrepreneurs.
Nick Kyrgios has since responded to the incident involving Marc Polmans. Read more here.
TUCSON, Ariz., October 03, 2023--Tucson Electric Power will build a large battery energy storage system to help satisfy customers’ energy needs with abundant, low-cost solar energy.
CHICAGO, October 03, 2023--Equity Residential (NYSE: EQR) today announced that the Company will release its third quarter 2023 operating results on Tuesday, October 31, 2023 after the close of market and host a conference call to discuss those results on Wednesday, November 1, 2023 at 10:00 a.m. Central. The conference call will be available via web cast on the Investor section of www.equityapartments.com.
(Article 223-16 of General Regulation of the French financial markets authority)PARIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting rights09/30/202355,583,76861,519,946 About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T immunotherap
The pop star celebrated her 54th birthday on Tuesday
CAMDEN, N.J., October 03, 2023--New Jersey American Water today completed its acquisition of the wastewater collection system of the Borough of Somerville, N.J. for $7 million. This municipally owned system serves approximately 3,800 customers, most of whom already receive water service from New Jersey American Water. On September 27, 2023, the New Jersey Board of Public Utilities approved the municipal consent allowing New Jersey American Water to provide sewer service to Somerville customers a
SAN FRANCISCO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company granted stock options to one new employee to purchase an aggregate of 30,000 shares of the Company's common stock, effective as of October 2, 2023. These awards were approved by the Compensation Com
Rocky Ridge K2 Special Edition Chevy. Rocky Ridge K2 Special Edition Chevy. 12 Different Color Combinations 12 Different Color Combinations FRANKLIN SPRINGS, Ga., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Rocky Ridge, a division of FOX Factory Performance Vehicle Development (PVD) group, is thrilled to announce the highly anticipated all-new Rocky Ridge K2 Special Edition Chevy Silverado 1500. The Rocky Ridge K2 Special Edition Chevy® 1500 encompasses all the elements of the Rocky Ridge legacy with a hi
ARCHBOLD, Ohio, Oct. 03, 2023 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) recently held its 6th Annual Ohio Charity Golf Classic and 2nd Annual Indiana Charity Golf Classic. Combined, the events raised $53,000 for local charities with record participation and donations at both events. The Ohio Charity Golf Classic hosted more than 140 golfers at Ironwood Golf Course in Wauseon, Ohio on August 25, 2023, raising $35,0
Vancouver, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spey Resources Corp. (CSE: SPEY) (OTC: SPEYF) (FRA: 2JS) ("Spey” or the "Company") is pleased to announce the appointment of Nader Vatanchi as Chief Executive Officer of the Company. Mr. Vatanchi has served on the Company’s Board of Directors since May 2021 and was formerly Chief Executive Officer of the Company from March 2021 to October 2022. The Company wishes to thank Philip Thomas for his tenure as Chief Executive Officer during
MESQUITE, NV, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. The company reports today that the packaging testing process is substantially completed with no non-conforming results. Testing completed to date includes assessment of labeling durability, Tyvek pouch packaging integrity, product stability under transport-related agitation, product stability under 6-mo
GREENWICH, Conn., Oct. 03, 2023 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced today that assets under management were $29.1 billion at September 30, 2023 as compared to $27.6 billion at September 30, 2022. GAMI expects to report third quarter 2023 diluted earnings in the range of $0.49 to $0.53 per share versus $0.36 per share for the third quarter of 2022. GAMI will be issuing further details on its financial results in early November. About GAMCO Investors, Inc. GA
DENVER, October 03, 2023--Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Wednesday, October 11
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced three poster presentations at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023), to be held in San Diego, California on November 1-5, 2023. Two of the posters will include new in vivo and in vitro data related to IO Biotech’s lead therapeutic cancer vaccine c
NEW YORK, October 03, 2023--Ares Management Corporation announced today that it will report earnings for the third quarter ending September 30, 2023 on Tuesday, October 31, 2023 prior to the opening of the New York Stock Exchange. Ares Management Corporation will hold its webcast/conference call on the same day at 11:00 a.m. (Eastern Time) to discuss its third quarter ending September 30, 2023 financial results.
CHARLOTTE, N.C., October 03, 2023--SEE (NYSE: SEE) announced today that it will release its third quarter 2023 results at approximately 7:00 a.m. (ET) on Thursday, November 2, 2023 and will host a conference call and webcast at 10:00 a.m. (ET).
ANDOVER, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, announced today that it successfully completed the repricing of its existing $3.6 billion secured tranche B term loan. The lenders have agreed to an amendment that results in a reduction of the interest rate for the tranche B term loans from SOFR plus a credit spread adjustment plus 275 basis points to SOFR plus 250 basis points. The reprici
LAFAYETTE, Ind., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC) today announced that it will webcast its quarterly earnings conference call to review and discuss its financial results for the third quarter 2023 on Wednesday, October 25, 2023 beginning at 12:00 p.m. ET. The call and an accompanying slide presentation will be accessible on the "Investors" section of Wabash’s website, www.onewabash.com, under "Events & Presentations." The conference call will be accessible by dialing (888) 44
CLEVELAND & LEXINGTON, Ky., October 03, 2023--Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, and Multipotent Adult Progenitor Cell (MAPC®) technology for equine, canine, and feline health applications, announces the signing of a licensing agreement with Ardent Animal Health (Ardent). Ardent is a privately held veterinary biotechnology company developing regenerative medicine and cancer therapies